Cover Image
Market Research Report
Product code 
1078048

Global Allergy Diagnostics and Therapeutics Market 2022-2028

Published: | Orion Market Research Pvt Ltd | 110 Pages | Delivery time: 2-3 business days

Price

Back to Top
Global Allergy Diagnostics and Therapeutics Market 2022-2028
Published: April 13, 2022
Orion Market Research Pvt Ltd
Content info: 110 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

Global Allergy Diagnostics and Therapeutics Market Size, Share & Trends Analysis Report, By Product (Instruments and Consumables), By Drug Class (Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergic, Immunomodulators, Auto-Injectable Epinephrine and Immunotherapy), By End-User (Diagnostic Labs, Hospitals and Academic Research Institutions), Forecast, 2022-2028

The global allergy diagnostics and therapeuticsmarket is anticipated to grow at a substantial CAGR of 11.4% during the forecast period. The rising environmental pollution levels such as air pollution, and allergens cause severe respiratory diseases and other diseases.For instance, according to the UN environment program(UNEP), Air pollution is the greatest environmental threat to public health globally and accounts for an estimated 7 million premature deaths every year. Around four million people died in 2019 from exposure to fine particulate outdoor air pollution, with the highest death rates occurring in Asia and Eastern Europe.

The global allergy diagnostics and therapeutics market is segmented based on products, drug class, and end-user. Based on products the market is sub-divided into instruments and consumables. Based on drug class the market is bifurcated into antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anticholinergic, immunomodulators, auto-injectable epinephrine, and immunotherapy.Based on end-user the marketis sub-segmented into diagnostic labs, hospitals, and academic research institutions. The hospital segment is anticipated to grow at the fastest rate, as hospitals assist the patients to take medical assistance under the observation ofexperienced surgeons.The increasing number of allergic patients along with growing awareness regarding the various benefits and facilities provided in hospitals is considered a prime factor that is supporting the growth of the hospital segment.

Geographically market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World.North America dominates the market and is expected to continue its presence over the forecast period. The growth can be attributed to the increasing number of food allergy patients and increasing adoption of allergy diagnostics and therapeutics solutions in allergy diagnosis as a result, the demand for allergy diagnostics and therapeutics for determining allergypresence is set to increase over the coming years, which has contributed to the growth of the market in the North America region. For instance, according to FARE peanuts were the most commonly specifically identified food causing anaphylaxis allergy accounting for 26% of the cases.Also common were egg allergies, crustacean allergies (e.g., allergies to shrimp or lobster), and dairy allergies, making up, respectively, 7 %, 6 %, and 5 %

The major companies serving the global allergy diagnostics and therapeuticsmarket are Hitachi Chemical Diagnostics, Inc., HOB Biotech GroupCorp., Ltd., Hycor Biomedical, LLC, Lincoln Diagnostics, Inc., Omega Diagnostics Group PLC,and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in 2020 HYCOR Biomedical and Changsha Haike Biotechnology Co., Ltd. had done registration with Hunan Medical Products Administration (HMPA) for the ALLEOS 2000 allergy testing system.

Research Methodology

The market study of the global allergy diagnostics and therapeuticsmarket is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, researchpapers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Allergy diagnostics and therapeuticsMarket Research and Analysis by Product

2. Global Allergy diagnostics and therapeuticsMarket Research and Analysis by Drug Class

3. Global Allergy diagnostics and therapeuticsMarket Research and Analysis by End-User

The Report Covers

  • Comprehensive research methodology of the globalallergy diagnostics and therapeutics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global allergy diagnostics and therapeuticsmarket.
  • Insights about market determinants that are stimulating the global allergy diagnostics and therapeuticsmarket.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Product Code: OMR2017101

Table of Contents

Category-Pharmaceuticals

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Allergy diagnostics and therapeutics Market
  • Recovery Scenario of Global Allergy diagnostics and therapeutics Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Thermo Fisher Scientific, Inc.
      • 3.1.1.1. Overview
      • 3.1.1.2. Financial Analysis
      • 3.1.1.3. SWOT Analysis
      • 3.1.1.4. Recent Developments
    • 3.1.2. Stallergenes Greer PLC
      • 3.1.2.1. Overview
      • 3.1.2.2. Financial Analysis
      • 3.1.2.3. SWOT Analysis
      • 3.1.2.4. Recent Developments
    • 3.1.3. Siemens AG
      • 3.1.3.1. Overview
      • 3.1.3.2. Financial Analysis
      • 3.1.3.3. SWOT Analysis
      • 3.1.3.4. Recent Developments
    • 3.1.4. BioMerieux SA
      • 3.1.4.1. Overview
      • 3.1.4.2. Financial Analysis
      • 3.1.4.3. SWOT Analysis
      • 3.1.4.4. Recent Developments
    • 3.1.5. Hitachi Chemical Diagnostics, Inc.
      • 3.1.5.1. Overview
      • 3.1.5.2. Financial Analysis
      • 3.1.5.3. SWOT Analysis
      • 3.1.5.4. Recent Developments
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of Covid-19 on Key Players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Allergy Diagnostics and Therapeutics Market, by Products
    • 5.1.1. Instruments
    • 5.1.2. Consumables
  • 5.2. Global Allergy Diagnostics and Therapeutics Market, by Drug class
    • 5.2.1. Antihistamines
    • 5.2.2. Decongestants
    • 5.2.3. Corticosteroids
    • 5.2.4. Mast Cell Stabilizers
    • 5.2.5. Leukotriene Inhibitors
    • 5.2.6. Nasal Anticholinergic
    • 5.2.7. Immunomodulators
    • 5.2.8. Auto Injectable Epinephrine
    • 5.2.9. Immunotherapy
  • 5.3. Global Allergy Diagnostics and Therapeutics Market, by End-User
    • 5.3.1. Diagnostic Labs
    • 5.3.2. Hospitals and Clinics
    • 5.3.3. Academic Research Institutions

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Allergan PLC
  • 7.2. ACON Laboratories, Inc.
  • 7.3. AESKU.GROUP GmbH
  • 7.4. Astra Biotech GmbH
  • 7.5. Allergy Therapeutics PLC
  • 7.6. bioMerieux SA
  • 7.7. Danaher Corp.
  • 7.8. Eurofins Scientific
  • 7.9. HAL Allergy Group
  • 7.10. Hitachi Chemical Diagnostics, Inc.
  • 7.11. HOB Biotech GroupCorp., Ltd.
  • 7.12. Hycor Biomedical, LLC
  • 7.13. Immunodiagnostic Systems Holdings PLC
  • 7.14. Lincoln Diagnostics, Inc.
  • 7.15. NEOGEN Corp
  • 7.16. Omega Diagnostics Group PLC
  • 7.17. PerkinElmer, Inc.
  • 7.18. Quest Diagnostics, Inc.
  • 7.19. R-Biopharm AG
  • 7.20. Romer Labs Division Holding
  • 7.21. Siemens AG
  • 7.22. Stallergenes Greer PLC
  • 7.23. Thermo Fisher Scientific, Inc.

LIST OF TABLES

  • 1. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BYPRODUCT, 2021-2028($ MILLION)
  • 2. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICSINSTRUMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS CONSUMABLES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
  • 5. GLOBAL ANTIHISTAMINES IN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL DECONGESTANTS IN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 7. GLOBAL CORTICOSTEROIDS IN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

8. GLOBAL MAST CELL STABILIZERS IN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION

  • 9. GLOBAL LEUKOTRIENE INHIBITORS IN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL NASAL ANTICHOLINERGIC IN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL IMMUNOMODULATORS IN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 12. GLOBAL AUTO-INJECTABLE EPINEPHRINE IN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 13. GLOBAL IMMUNOTHERAPY IN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 14. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 15. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICSIN DIAGNOSTIC LABS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 16. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS IN HOSPITALSAND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 17. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS IN ACADEMIC RESEARCH INSTITUTIONSMARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 18. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
  • 19. NORTH AMERICAN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 20. NORTH AMERICAN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
  • 21. NORTH AMERICAN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
  • 22. NORTH AMERICAN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 23. EUROPEAN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 24. EUROPEAN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
  • 25. EUROPEAN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
  • 26. EUROPEAN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 27. ASIA-PACIFIC ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 28. ASIA-PACIFIC ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
  • 29. ASIA-PACIFIC ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
  • 30. ASIA-PACIFIC ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY END-USER 2021-2028 ($ MILLION)
  • 31. REST OF THE WORLD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
  • 32. REST OF THE WORLD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
  • 33. REST OF THE WORLD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)

LIST OF FIGURES

1. IMPACT OF COVID-19 ON GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET, 2020-2027 (% MILLION)

2. IMPACT OF COVID-19 ON GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY SEGMENT, 2020-2027 (% MILLION)

  • 3. RECOVERY OF GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET, 2020-2027 (%)
  • 4. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SHARE BY PRODUCT, 2021 VS 2028 (%)
  • 5. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SHARE BY DRUG CLASS, 2021 VS 2028 (%)
  • 6. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SHARE BY END-USER, 2021 VS 2028 (%)
  • 7. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 8. GLOBAL ANTIHISTAMINES IN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 9. GLOBAL DECONGESTANTS IN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 10. GLOBAL CORTICOSTEROIDS IN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 11. GLOBAL MAST CELL STABILIZERS IN ALLERGY DIAGNOSTICS AND THERAPEUTICS SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 12. GLOBAL LEUKOTRIENE INHIBITORS IN ALLERGY DIAGNOSTICS AND THERAPEUTICS SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 13. GLOBAL NASAL ANTICHOLINERGIC IN ALLERGY DIAGNOSTICS AND THERAPEUTICS SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 14. GLOBAL IMMUNOMODULATORS IN ALLERGY DIAGNOSTICS AND THERAPEUTICS SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 15. GLOBAL AUTO-INJECTABLE EPINEPHRINE IN ALLERGY DIAGNOSTICS AND THERAPEUTICS SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 16. GLOBAL IMMUNOTHERAPY IN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 17. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICSIN DIAGNOSTIC LABS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 18. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS IN HOSPITALSAND CLINICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 19. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS IN ACADEMIC RESEARCH INSTITUTIONS SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 20. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)US ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. CANADA ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. UK ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. FRANCE ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. GERMANY ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. ITALY ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. SPAIN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. ROE ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. INDIA ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 29. CHINA ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 30. JAPAN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 31. REST OF ASIA-PACIFIC ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 32. REST OF THE WORLD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)